Stay updated on Pirfenidone in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page
- Check5 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a study evaluating pirfenidone for severe or critical novel coronavirus infection, including its design, eligibility criteria, outcomes, and study contacts. It also includes the study’s record dates, publications, and related drug and disease information.SummaryDifference46%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide banner announces an NIH website transition and says that content may use “Super Intelligence” instead of “Artificial Intelligence” during the change.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1. The study page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedA 403 Forbidden page now appears for this study record, replacing the usual content and removing sections such as results, publications, and contact details. The page shows a minimal header and a 403 message, indicating access restrictions.SummaryDifference18%

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.